1. Home
  2. CRESY vs CSTL Comparison

CRESY vs CSTL Comparison

Compare CRESY & CSTL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cresud S.A.C.I.F. y A.

CRESY

Cresud S.A.C.I.F. y A.

HOLD

Current Price

$10.91

Market Cap

738.3M

Sector

Finance

ML Signal

HOLD

Logo Castle Biosciences Inc.

CSTL

Castle Biosciences Inc.

HOLD

Current Price

$31.52

Market Cap

722.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CRESY
CSTL
Founded
1936
2007
Country
Argentina
United States
Employees
2889
N/A
Industry
Real Estate
Medical Specialities
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
738.3M
722.8M
IPO Year
N/A
2019

Fundamental Metrics

Financial Performance
Metric
CRESY
CSTL
Price
$10.91
$31.52
Analyst Decision
Strong Buy
Analyst Count
0
6
Target Price
N/A
$45.50
AVG Volume (30 Days)
239.9K
390.6K
Earning Date
05-07-2026
05-06-2026
Dividend Yield
8.14%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$344,229,000.00
Revenue This Year
N/A
$2.42
Revenue Next Year
N/A
$12.69
P/E Ratio
$6.92
N/A
Revenue Growth
N/A
3.66
52 Week Low
$8.39
$17.72
52 Week High
$14.21
$44.28

Technical Indicators

Market Signals
Indicator
CRESY
CSTL
Relative Strength Index (RSI) 51.30 74.87
Support Level $11.12 $22.67
Resistance Level $11.84 $34.97
Average True Range (ATR) 0.39 1.45
MACD 0.03 0.55
Stochastic Oscillator 60.77 89.62

Price Performance

Historical Comparison
CRESY
CSTL

About CRESY Cresud S.A.C.I.F. y A.

Cresud SACIF y A is a Latin American agricultural firm producing basic commodities with a growing presence in Argentina, Brazil, and other countries through its investment in Brasilagro. It focuses on grains, sugarcane, and cattle farming, acquiring and developing agricultural properties for production or value appreciation, and occasionally selling appreciated land. It also leases land and offers agency and agro-industrial services. Operations are divided into two segments: agricultural business (production, land transformation and sales, corporate services) and urban properties and investments (shopping malls, offices, sales, developments, hotels, and related activities).

About CSTL Castle Biosciences Inc.

Castle Biosciences Inc is a molecular diagnostics company. The group provides test solutions for the diagnosis and treatment of dermatologic cancers, Barrett's esophagus (BE), and uveal melanoma. The product portfolio of the company includes DecisionDx-Melanoma, a risk stratification gene expression profile (GEP) test; DecisionDx-SCC, a risk stratification test for cutaneous squamous cell carcinoma; MyPath Melanoma, a diagnostic GEP test for use in patients with difficult-to-diagnose melanocytic lesions; and TissueCypher, a test to predict future development of progression of high-grade dysplasia and/or esophageal cancer. The company derives revenues through the delivery of test reports for its molecular diagnostic tests.

Share on Social Networks: